rs4252583

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The ENST00000526180.6(CRYAB):​c.-224-150C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00802 in 275,266 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.012 ( 34 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 4 hom. )

Consequence

CRYAB
ENST00000526180.6 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.02

Publications

1 publications found
Variant links:
Genes affected
CRYAB (HGNC:2389): (crystallin alpha B) Mammalian lens crystallins are divided into alpha, beta, and gamma families. Alpha crystallins are composed of two gene products: alpha-A and alpha-B, for acidic and basic, respectively. Alpha crystallins can be induced by heat shock and are members of the small heat shock protein (HSP20) family. They act as molecular chaperones although they do not renature proteins and release them in the fashion of a true chaperone; instead they hold them in large soluble aggregates. These heterogeneous aggregates consist of 30-40 subunits; the alpha-A and alpha-B subunits have a 3:1 ratio, respectively. Two additional functions of alpha crystallins are an autokinase activity and participation in the intracellular architecture. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Alpha-A and alpha-B gene products are differentially expressed; alpha-A is preferentially restricted to the lens and alpha-B is expressed widely in many tissues and organs. Elevated expression of alpha-B crystallin occurs in many neurological diseases; a missense mutation cosegregated in a family with a desmin-related myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2019]
CRYAB Gene-Disease associations (from GenCC):
  • myofibrillar myopathy 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • cataract 16 multiple types
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • fatal infantile hypertonic myofibrillar myopathy
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet
  • early-onset lamellar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset posterior polar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy 1II
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 11-111912098-G-A is Benign according to our data. Variant chr11-111912098-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1207966.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0123 (1869/152238) while in subpopulation AFR AF = 0.0396 (1643/41510). AF 95% confidence interval is 0.038. There are 34 homozygotes in GnomAd4. There are 861 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 34 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRYABNM_001289807.1 linkc.-198-176C>T intron_variant Intron 1 of 3 NP_001276736.1 P02511V9HW27
CRYABNM_001368245.1 linkc.-198-176C>T intron_variant Intron 1 of 3 NP_001355174.1
CRYABNM_001885.3 linkc.-198-176C>T intron_variant Intron 1 of 3 NP_001876.1 P02511V9HW27

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRYABENST00000526180.6 linkc.-224-150C>T intron_variant Intron 1 of 3 1 ENSP00000436051.1 P02511
CRYABENST00000527899.6 linkc.-198-176C>T intron_variant Intron 1 of 3 2 ENSP00000436089.2 P02511
CRYABENST00000527950.5 linkc.-198-176C>T intron_variant Intron 1 of 3 5 ENSP00000437149.1 P02511

Frequencies

GnomAD3 genomes
AF:
0.0123
AC:
1867
AN:
152120
Hom.:
34
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0396
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00923
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.000750
Gnomad OTH
AF:
0.00957
GnomAD4 exome
AF:
0.00276
AC:
339
AN:
123028
Hom.:
4
Cov.:
0
AF XY:
0.00231
AC XY:
149
AN XY:
64590
show subpopulations
African (AFR)
AF:
0.0379
AC:
184
AN:
4856
American (AMR)
AF:
0.00665
AC:
42
AN:
6316
Ashkenazi Jewish (ASJ)
AF:
0.00208
AC:
7
AN:
3370
East Asian (EAS)
AF:
0.000285
AC:
2
AN:
7016
South Asian (SAS)
AF:
0.00
AC:
0
AN:
16362
European-Finnish (FIN)
AF:
0.000219
AC:
1
AN:
4562
Middle Eastern (MID)
AF:
0.0120
AC:
6
AN:
498
European-Non Finnish (NFE)
AF:
0.000939
AC:
69
AN:
73492
Other (OTH)
AF:
0.00427
AC:
28
AN:
6556
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0123
AC:
1869
AN:
152238
Hom.:
34
Cov.:
32
AF XY:
0.0116
AC XY:
861
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0396
AC:
1643
AN:
41510
American (AMR)
AF:
0.00922
AC:
141
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.000750
AC:
51
AN:
68020
Other (OTH)
AF:
0.00947
AC:
20
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0107
Hom.:
7
Bravo
AF:
0.0148
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 26, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.9
DANN
Benign
0.32
PhyloP100
1.0
PromoterAI
-0.31
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4252583; hg19: chr11-111782822; API